TScan Therapeutics Statistics

Total Valuation

TCRX has a market cap or net worth of $61.29 million. The enterprise value is -$27.54 million.

Market Cap	61.29M
Enterprise Value	-27.54M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TCRX has 56.75 million shares outstanding. The number of shares has increased by 6.36% in one year.

Current Share Class	52.47M
Shares Outstanding	56.75M
Shares Change (YoY)	+6.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.76%
Owned by Institutions (%)	47.81%
Float	44.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.28
Forward PS	7.79
PB Ratio	0.43
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.44, with a Debt / Equity ratio of 0.66.

Current Ratio	6.44
Quick Ratio	6.32
Debt / Equity	0.66
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-52.15

Financial Efficiency

Return on equity (ROE) is -76.44% and return on invested capital (ROIC) is -33.24%.

Return on Equity (ROE)	-76.44%
Return on Assets (ROA)	-30.45%
Return on Invested Capital (ROIC)	-33.24%
Return on Capital Employed (ROCE)	-63.80%
Revenue Per Employee	$43,195
Profits Per Employee	-$731,272
Employee Count	195
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.73% in the last 52 weeks. The beta is 1.03, so TCRX's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	-75.73%
50-Day Moving Average	1.63
200-Day Moving Average	1.63
Relative Strength Index (RSI)	41.29
Average Volume (20 Days)	870,092

Short Selling Information

The latest short interest is 1.95 million, so 3.44% of the outstanding shares have been sold short.

Short Interest	1.95M
Short Previous Month	1.74M
Short % of Shares Out	3.44%
Short % of Float	4.43%
Short Ratio (days to cover)	2.16

Income Statement

In the last 12 months, TCRX had revenue of $8.42 million and -$142.60 million in losses. Loss per share was -$2.51.

Revenue	8.42M
Gross Profit	-12.54M
Operating Income	-148.67M
Pretax Income	-142.60M
Net Income	-142.60M
EBITDA	-145.81M
EBIT	-148.67M
Loss Per Share	-$2.51

Full Income Statement

Balance Sheet

The company has $184.45 million in cash and $95.62 million in debt, giving a net cash position of $88.83 million or $1.57 per share.

Cash & Cash Equivalents	184.45M
Total Debt	95.62M
Net Cash	88.83M
Net Cash Per Share	$1.57
Equity (Book Value)	144.02M
Book Value Per Share	2.54
Working Capital	158.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$130.73 million and capital expenditures -$5.12 million, giving a free cash flow of -$135.85 million.

Operating Cash Flow	-130.73M
Capital Expenditures	-5.12M
Free Cash Flow	-135.85M
FCF Per Share	-$2.39

Full Cash Flow Statement

Margins

Gross Margin	-148.85%
Operating Margin	-1,765.01%
Pretax Margin	-1,692.96%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.36%
Shareholder Yield	-6.36%
Earnings Yield	-232.67%
FCF Yield	-221.66%

Analyst Forecast

The average price target for TCRX is $8.50, which is 687.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	687.04%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	79.35%
EPS Growth Forecast (5Y)	-33.56%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TCRX has an Altman Z-Score of -2.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.98
Piotroski F-Score	1